Several CAR T-cell therapies have already been granted approval by the FDA and EMA, but the field is broadening. New therapies are tapping into stem cells, T-cell receptors (TCR), tumor-infiltrating lymphocytes, macrophages, and NK-cells to explore their therapeutic potential.
While these therapies can be more effective at targeting solid tumors, they face barriers throughout development.
Gain the insights needed to understand and overcome the unique clinical, translational, logistical, and manufacturing challenges associated with developing a novel cell therapy in this free ungated eBook.
Within this resource, we go into detail on the current and future state of cell therapy development.